Dergiler / Respiratory Case Reports / 2019 / Cilt: 8 - Sayı: 1

A Case of Invasive Pulmonary Aspergillosis in an Immunocompetent Patient Diagnosed by EBUS-TBNA, Misdiagnosed as Lung Cancer

Akciğer Kanseri Olarak Yanlış Tanı Alan İmmün Sistemi Sağlıklı EBUS-TBİA ile İnvazif Pulmoner Aspergillozis Tanısının Konan Bir Olgu

Sayfa
1–5
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The role of EBUS-TBNA in the histological diagnosis of mass like lung lesions is expected to expand.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aspergillus species are widely distributed in nature.
📊
Temel Bulgular & Veri:A 68-year-old female was referred to the department of pulmonology for right upper chest pain for two weeks.
💡
Sonuç & Katkı:The role of EBUS-TBNA in the histological diagnosis of mass like lung lesions is expected to expand.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aspergillus species are widely distributed in nature. Aspergillus can cause life-threatening invasive pulmonary aspergillosis (IPA) in patients with impaired immune function. IPA is difficult to diagnose because the symptoms are nonspecific, and the radiologic findings can be various. A 68-year-old female was referred to the department of pulmonology for right upper chest pain for two weeks. Computedtomography (CT) scan showed suspicion of lung cancer, then endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed. IPA was diagnosed histologically. In Korea, this is the first report of IPA diagnosed through EBUSTBNA. The role of EBUS-TBNA in the histological diagnosis of mass like lung lesions is expected to expand.

Abstract

Aspergillozis örnekleri doğada yaygın olarak bulunmaktadır. Aspergillus, immün sistemi bozulmuş hastalarda hayatı tehdit eden invazif pulmoner aspergillozise (IPA) neden olabilmektedir. IPA semptomları nonspesifik ve radyolojik bulguları çeşitli olduğu için tanısı zor bir hastalıktır. Göğüs üst kısmında iki haftadır devam ağrı nedeniyle, 68 yaşındaki kadın hasta Göğüs Hastalıkları bölümüne yönlendirilmişti. Bilgisayarlı tomografide akciğer kanserinden şüphe edildi. Endobronşial ultrason rehberliğinde transbronşial iğne aspirasyonu (EBUS-TBİA) yapıldı ve IPA tanısı histolojik olarak kondu. Bu, Kore’de EBUS-TBİA ile IPA tanısı konan ilk olgu sunumudur. Kitlesel akciğer lezyonlarının tanısında EBUS-TBİA’nın rolünün artması beklenmektedir.

🔖

Bu Makaleye Atıf Yap

KIM, T., CHO, H., LEE, J., KIM, J. (2019). A Case of Invasive Pulmonary Aspergillosis in an Immunocompetent Patient Diagnosed by EBUS-TBNA, Misdiagnosed as Lung Cancer. Respiratory Case Reports, Cilt: 8 - Sayı: 1, 1–5. https://ajindex.com/articles/302408

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Jung JY, Kim MS, Park JY, Cho EB, Park EJ, Kim KH, et al. A Case of Cutaneous Aspergillus flavus Infection in an Immunocompetent Patient. Korean J Med Mycol 2016
  2. [CrossRef] 2. Kristan SŠ, Kern I, Mušič E. Invasive pulmonary aspergillosis. Respiration 2002
  3. [CrossRef] 3. Park SY, Lee EJ, Kim TH, Choo EJ, Jeon MH, Kong MG, et al. The Clinical Characteristics, Therapeutic Outcome and Prognostic Factors for Invasive Pulmonary Aspergillosis: A Single-Center Experience and Review of the Literature. Korean J Med Mycol 2012
  4. [CrossRef] 4. Song JG, Kang SH, Jung BW, Oh HS, Kim MJ, Lee SH. Invasive Pulmonary Aspergillosis Histologically Mimicking Mucormycosis. Ewha Med J 2016
  5. [CrossRef] 5. Garnacho-Montero J, Olaechea P, Alvarez-Lerma F, Alvarez-Rocha L, Blanquer J, Galván B, et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. Rev Esp Quimioter 2013
  6. Jeong DW, Lee S-H, Moon J-Y, Kim Y-G, Lee YH, Kim K, et al. Fatal Invasive Pulmonary Aspergillosis after Combined Induction with Rituximab and Antithymocyte Globulin for Kidney Transplantation in a Sensitized Recipient, and Early Rejection Therapy with Plasmapheresis and Low-dose Immunoglobulin. J Korean Soc Transplant 2017
  7. [CrossRef] 7. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008
  8. [CrossRef] 8. Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1→ 3)-β-d-glucan, and consequences of delayed antifungal therapy. Antimicrob Agents Chemother 2010
  9. [CrossRef] 9. Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 2002
  10. [CrossRef] 10. Greene RE, Schlamm HT, Oestmann J-W, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007
  11. [CrossRef] 11. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbre